These are exciting times, with fresh news about research developments appearing every week.
Find out about the latest research news below and also visit our Breaking News in Research page.
Our MDUK Muscles Matter 2020 seminars continued on Monday 14 September, virtually bringing together people living with muscle-wasting conditions from across the UK.Read more
NICE widens scope of its appraisal of Zolgensma TM
A clinical trial is under way for EPM-01 – a potential treatment for boys and men with Becker muscular dystrophy that has shown early promise.
Muscular Dystrophy UK has provided funding for Professors Muntoni and Bönneman for their project-work relating to collagen VI-related myopathies.
An update from MDUK on research
MDUK and Healx announce new partnership to identify FSHD treatments
AMRC calls on Government to match-fund charity research
A recent survey by the Association of Medical Research Charities (AMRC) has found that members – including Muscular Dystrophy UK – will experience an average loss of 38 percen
Roche, the pharmaceutical company behind the SMA treatment Risdiplam, has extended its compassionate use programme to potentially include patients who cannot receive Spinraza becau
Joint letter to NICE regarding the suspension of the appraisal process for ridisplam
Muscular Dystrophy UK regrets to announce that, due to the financial effect Covid-19 is having on our ability to generate income, we are cancelling the current Grant Round in 2020.